In this episode, host JP Valentine sits down with Rohit Nambisan, President at Lokavant in New York. Lokavant is a technology company whose mission is to ensure that no clinical trial fails due to operational error. By integrating and analyzing the disparate data sources within clinical trials, Lokavant provides real-time visualizations and risk alerts to study sponsors and CROs to enable data-driven decisions. These insights expedite trial timelines and reduce the costs of development, allowing safe and efficacious treatments to get to patients.

Lokavant centralizes trial data to power a machine learning model that anticipates trial risk, provides data-driven risk mitigation strategies and predicts the impact of mitigation strategy implementation. Lokavant's anticipatory monitoring capability is grounded in a compendium of data from over 1,000 clinical trials and will improve with each deployment.

In the show, Rohit will share with you:

How Lokavant aim to impact the Healthcare sector,

Using data to positively impact clinical trials,

How the Coronavirus pandemic is disrupting clinical trials,

Lokovant’s solutions in response to COVID-19,

Why he loves working in the Healthtech industry,

and What the future looks like for Lokavant